Day: January 18, 2024

HUNTINGTON BEACH, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) — via IBN – Nate’s Food Co. (OTC: NHMD) announces that the company has successfully secured a purchase order for 49,000,000 barrels of jet fuel, with an estimated value of nearly $5 billion based on current Platts pricing. The deal is structured as follows: • An initial transaction of 1,000,000 barrels of jet fuel. • Subsequent monthly deliveries of 4,000,000 barrels for a duration of 12 months. This purchase order was made possible by our recent joint venture (JV) partnership that was announced last week. The partnership has enabled us to ensure a consistent and reliable supply of jet fuel from a reputable refinery, streamlining the entire process between our JV partner and our buyers. To guarantee the successful execution of this order, Nate’s Food Co is currently...

SEATTLE, Jan. 18, 2024 (GLOBE NEWSWIRE) —  Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced the pricing of an underwritten public offering of 132,075,218 shares of its common stock at a public offering price of $0.37 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 30,086,944 shares of its common stock at a price of $0.369 per pre-funded warrant. The aggregate gross proceeds from this public offering are expected to be approximately $60.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Perspective in connection with the public offering. The purchase price per share...

Verkkokauppa.com Oyj                 STOCK EXCHANGE RELEASE         18 January 2024 at 2:00 p.m. EET Shareholders’ Nomination Board’s proposals regarding the composition and remuneration of the Board of Directors of Verkkokauppa.com Oyj – Irmeli Rytkönen and Enel Sintonen proposed as new members Verkkokauppa.com Oyj’s Shareholders’ Nomination Board will propose to the Annual General Meeting, planned to be held on 4 April 2024, that the Board of Directors consists of seven members and that the following persons be elected as Board members for a term ending at the close of the Annual General Meeting 2025: Proposed to be re-elected as members: Robin Bade, Henrik Pankakoski, Kati Riikonen, Samuli Seppälä and Arja Talma Proposed to be elected as new members: Irmeli Rytkönen and Enel Sintonen Of the current members, Johan Ryding and Kai...

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the appointment of Sean McLoughlin as Chief Operating Officer. As part of a planned transition in connection with Mr. McLoughlin’s appointment, Co-founder and current Chief Operating Officer Dr. Aditya Kohli will remain a full-time executive with the company as Chief Business Officer, where he will be responsible for business development and corporate strategy.  Mr. McLoughlin has three decades of commercial and operational experience in vaccines, most recently as the Global Vaccine Commercialization Lead, RSV at GSK. In this capacity, he was responsible for the successful commercial launch of GSK’s RSV product AREXVY. Prior to that Mr. McLoughlin...

Press ReleaseNokia and Zayo achieve new North American distance record for 800Gb/s transmission on live networkNorth American transmission record of 800Gb/s over 1866km using a single wavelength over 23 spans over a C+L WDM line system Companies also achieved single wavelength one Terabit per second (1 Tb/s) transmission over 1004kms using 150GHz channels showing ability to reach even higher capacity on high traffic routes Challenging distance records addresses soaring traffic demand resulting from an increasingly digitized world18 Jan 2023Espoo, Finland – Nokia and Zayo have announced the successful completion of a live field trial of Nokia’s sixth-generation Photonic Service Engine super-coherent optics (PSE-6s), demonstrating a North American transmission record of 800Gb/s over a single wavelength from LA to El Paso on a...

Presentation to include additional results from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies WALTHAM, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of an abstract for oral presentation at the Best Abstracts session of the upcoming Tandem Meetings: Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT®) and the Center for International Blood and Marrow Transplant Research (CIBMTR®), being held from February 21-24, 2024, in San Antonio, Texas and online. The presentation will highlight initial...

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), today announced the 2024 OTCQX® Best 50, a ranking of the top-performing OTCQX companies in the prior calendar year. The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX Best Market, based on an equal weighting of one-year total return and average daily dollar volume growth. Companies in the 2024 OTCQX Best 50 were ranked based on their performance during the 2023 calendar year. “We congratulate this year’s OTCQX Best 50 companies on their ability to achieve a high level of performance during another challenging year for market conditions,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “This year’s roster represents a diverse set of industries and geographies...

– The raise includes $500 million in cash from Blue Owl and CPP Investments in exchange for a 5% royalty on future global net sales of acoramidis – The raise also includes a $450 million credit facility from Blue Owl that refinances existing senior secured credit, extending maturity from 2026 to 2029 subject to certain conditions – Additionally, the agreement with Blue Owl provides for the possibility of additional incremental facilities of up to $300 million of credit to support strategic pipeline expansion and acceleration – With this financing BridgeBio enters 2024 well capitalized to launch acoramidis and continue to accelerate its industry-leading genetic medicine R&D engine PALO ALTO, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage...

BUFORD, Ga., Jan. 18, 2024 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (the “Company” or “OneWater”) announced today that it will release its first quarter 2024 financial results on Thursday, February 1st, 2024, before the market opens. Following the release, the Company’s management team will host a conference call to discuss the results at 8:30 a.m. Eastern Time that day. To access via phone, participants can use the dial in below: Event: OneWater Marine Inc. Fiscal First Quarter 2024 Conference Call Date: Thursday, February 1, 2024 Time: 8:30 a.m. Eastern Time Live Call: 1-833-630-0581 or 1-412-317-1814 (International) OneWater Marine will offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company’s website, at https://investor.onewatermarine.com/...